Drug Pipeline

Paclitaxel for Injection (albumin bound ) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
4
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06752811 Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer Pancreatic Cancer Metastatic Recruiting
NCT07418749 A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With… Recurrent Cervical Cancer Recruiting
NCT07165951 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules… Metastatic Pancreatic Ductal Adenocarcinoma Recruiting
Phase 2/3
NCT07165886 Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in… Gastroenteropancreatic Neuroendocrine Tumors Recruiting
Phase 1/2
NCT06821503 Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ±… Advanced Pancreatic Cancer Recruiting
Sponsors Running Paclitaxel for Injection (albumin bound ) Trials
Shanghai Yizhong Pharmaceutical Co., Ltd. (1) Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. (1) Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
Disease Areas
Pancreatic Cancer (3) Cervical Cancer (1)
Get alerts when Paclitaxel for Injection (albumin bound ) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free